Pemetrexed and its emerging role in the treatment of thoracic malignancies

Author： Scagliotti Giorgio V Novello Silvia

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.5, 2003-05, pp. : 853-863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial

By Gridelli Cesare Di Maio Massimo

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 321-324

Informa Healthcare

Access to resources Recommend Favorite

The Role of microRNAs in the Pathogenesis and Treatment of Hematopoietic Malignancies

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1201-1210

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2075-2084

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies

By Jain Nitin Odenike Olatoyosi

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 3073-3084

Informa Healthcare

Access to resources Recommend Favorite

Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 790-800

Bentham Science Publishers

Access to resources Recommend Favorite